Header Logo

Connection

NADER EL-MALLAWANY to Male

Back to Details
This is a "connection" page, showing publications NADER EL-MALLAWANY has written about Male.
NADER EL-MALLAWANY
Connection Strength
0.214
Male
  1. Divergent clinical presentations and outcomes among children and adolescents with Kaposi sarcoma in Malawi and Tanzania. HIV Med. 2023 06; 24(6):664-675.
    View in: PubMed
    Score: 0.026
  2. Kaposi Sarcoma Herpesvirus Inflammatory Cytokine Syndrome-like Clinical Presentation in Human Immunodeficiency Virus-infected Children in Malawi. Clin Infect Dis. 2019 11 13; 69(11):2022-2025.
    View in: PubMed
    Score: 0.021
  3. KSHV viral load and Interleukin-6 in HIV-associated pediatric Kaposi sarcoma-Exploring the role of lytic activation in driving the unique clinical features seen in endemic regions. Int J Cancer. 2019 01 01; 144(1):110-116.
    View in: PubMed
    Score: 0.019
  4. Proposal of a Risk-Stratification Platform to Address Distinct Clinical Features of Pediatric Kaposi Sarcoma in Lilongwe, Malawi. J Glob Oncol. 2018 09; 4:1-7.
    View in: PubMed
    Score: 0.018
  5. Identifying opportunities to bridge disparity gaps in curing childhood cancer in Malawi: Malignancies with excellent curative potential account for the majority of diagnoses. Pediatr Hematol Oncol. 2017 Aug; 34(5):261-274.
    View in: PubMed
    Score: 0.018
  6. Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study. PLoS One. 2016; 11(4):e0153335.
    View in: PubMed
    Score: 0.016
  7. Long-term remission in a child with refractory EBV(+) hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV(+)-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy. Bone Marrow Transplant. 2011 May; 46(5):759-61.
    View in: PubMed
    Score: 0.011
  8. Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis. Br J Haematol. 2024 May; 204(5):1888-1893.
    View in: PubMed
    Score: 0.007
  9. Clinical, radiological and molecular responses to combination chemotherapy with MAPK pathway inhibition in relapsed and refractory Langerhans cell histiocytosis. Br J Haematol. 2024 May; 204(5):1882-1887.
    View in: PubMed
    Score: 0.007
  10. Childhood and Adolescent Relapsed/Refractory Aggressive B-Cell Lymphomas With t(8;14) and BCL2 Expression, Burkitt Lymphoma Versus Diffuse Large B-Cell Lymphoma: A Diagnostic Challenge. Pediatr Dev Pathol. 2024 Jul-Aug; 27(4):348-353.
    View in: PubMed
    Score: 0.007
  11. Genetic errors of immunity distinguish pediatric nonmalignant lymphoproliferative disorders. J Allergy Clin Immunol. 2022 02; 149(2):758-766.
    View in: PubMed
    Score: 0.006
  12. Disseminated cysticercosis and Kaposi sarcoma in a child with HIV/AIDS: A case report. BMC Infect Dis. 2020 Apr 25; 20(1):309.
    View in: PubMed
    Score: 0.005
  13. A clinicopathologic study of the spectrum of systemic forms of EBV-associated T-cell lymphoproliferative disorders of childhood: A single tertiary care pediatric institution experience in North America. Pediatr Blood Cancer. 2019 08; 66(8):e27798.
    View in: PubMed
    Score: 0.005
  14. Prospective study of Burkitt lymphoma treatment in adolescents and adults in Malawi. Blood Adv. 2019 02 26; 3(4):612-620.
    View in: PubMed
    Score: 0.005
  15. Risk factors and reasons for treatment abandonment among children with lymphoma in Malawi. Support Care Cancer. 2018 Mar; 26(3):967-973.
    View in: PubMed
    Score: 0.005
  16. Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report. Br J Haematol. 2017 05; 177(4):601-611.
    View in: PubMed
    Score: 0.004
  17. Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi. Int J Cancer. 2017 06 01; 140(11):2509-2516.
    View in: PubMed
    Score: 0.004
  18. Quantifying bias in survival estimates resulting from loss to follow-up among children with lymphoma in Malawi. Pediatr Blood Cancer. 2017 06; 64(6).
    View in: PubMed
    Score: 0.004
  19. Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study. Pediatr Blood Cancer. 2017 05; 64(5).
    View in: PubMed
    Score: 0.004
  20. Adolescent and young adult non-Hodgkin lymphoma. Br J Haematol. 2016 05; 173(4):637-50.
    View in: PubMed
    Score: 0.004
  21. Outcomes for paediatric Burkitt lymphoma treated with anthracycline-based therapy in Malawi. Br J Haematol. 2016 06; 173(5):705-12.
    View in: PubMed
    Score: 0.004
  22. Clinical characteristics and outcomes of HIV-infected children diagnosed with Kaposi sarcoma in Malawi and Botswana. Pediatr Blood Cancer. 2013 Aug; 60(8):1274-80.
    View in: PubMed
    Score: 0.003
  23. Adenovirus infection in paediatric allogeneic stem cell transplantation recipients is a major independent factor for significantly increasing the risk of treatment related mortality. Br J Haematol. 2012 Jan; 156(1):99-108.
    View in: PubMed
    Score: 0.003
  24. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood. 2011 Jun 02; 117(22):5835-49.
    View in: PubMed
    Score: 0.003
  25. Spectrum of childhood Epstein-Barr virus-associated T-cell proliferations and bone marrow findings. Pediatr Dev Pathol. 2011 Jan-Feb; 14(1):28-37.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.